AIkido Pharma Inc AIKI

NAS: AIKI | ISIN: US84842R5028   22/02/2023
3,800 USD (-2,81%)
(-2,81%)   22/02/2023

21 juni 2023 · Dominari Securities CEO, Kyle Wool, Discusses the IPO Market on "The Claman Countdown" · Persbericht

3 april 2023 · Dominari Holdings Appoints George Way Chief Financial Officer · Persbericht

24 februari 2023 · Dominari Holdings Provides Update on Share Repurchase Program · Persbericht

28 december 2022 · Dominari Holdings Provides Update on Share Repurchase Program · Persbericht

22 december 2022 · AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH) · Persbericht

28 november 2022 · AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes · Persbericht

6 oktober 2022 · AIkido Share Repurchase Continues · Persbericht

5 oktober 2022 · AIkido Purchases More Shares · Persbericht

4 oktober 2022 · Share Repurchase Program Continues · Persbericht

3 oktober 2022 · AIkido Pharma Continues Share Repurchase Program · Persbericht

30 september 2022 · AIkido Pharma Provides Update on Share Repurchase Program · Persbericht

10 september 2022 · Dominari Financial, Inc. Executes Definitive Agreement to Buy Broker-Dealer · Persbericht

10 augustus 2022 · AIkido Pharma Confirms Receipt of Unsolicited Offer · Persbericht

21 juli 2022 · AIkido Pharma, Inc. Hires Carlos Aldavero to Lead Financial Services Subsidiary · Persbericht

28 juni 2022 · AIkido Pharma Inc. Regains Compliance with NASDAQ Listing Requirements · Persbericht

24 juni 2022 · AIkido Inc. Announces the Formation of a New Financial Services Subsidiary · Persbericht

10 juni 2022 · AIkido Pharma Inc. Appoints New Director, Soo Yu · Persbericht

3 juni 2022 · AIkido Announces Reverse Stock Split · Persbericht

19 mei 2022 · AIkido Pharma Announces Company Commitment to Board Diversity · Persbericht

12 mei 2022 · AIkido Pharma Secures Interest in Databricks Inc. · Persbericht

Mijn selecties